Coverage with evidence development
Revision as of 12:21, 8 November 2023 by Editor iHTS (talk | contribs) (Created page with "Early funding of a health technology conditional on gathering additional evidence to address the sources of uncertainty. '''Note 1:''' The uncertainty usually relates to a specific aspect of the effectiveness or cost-effectiveness. '''Note 2:''' Synonyms include access with evidence development, and managed access. '''Note 3:''' Related terms include managed entry scheme/agreement, risk share agreement, interim funding, evidence development, conditional reimbursement,...")
Early funding of a health technology conditional on gathering additional evidence to address the sources of uncertainty.
Note 1: The uncertainty usually relates to a specific aspect of the effectiveness or cost-effectiveness.
Note 2: Synonyms include access with evidence development, and managed access.
Note 3: Related terms include managed entry scheme/agreement, risk share agreement, interim funding, evidence development, conditional reimbursement, and conditional coverage.